Search Results for: Diabetes

3097 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
HHEX and TLE1 hematopoietically expressed homeobox transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • APC truncation mutants have impaired AXIN binding
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • Signaling by Wnt
  • deactivation of the beta-catenin transactivating complex
  • APC truncation mutants are not K63 polyubiquitinated
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • S37 mutants of beta-catenin aren't phosphorylated
  • Degradation of beta-catenin by the destruction complex
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • RNF mutants show enhanced WNT signaling and proliferation
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • truncations of AMER1 destabilize the destruction complex
  • FBXW7 Mutants and NOTCH1 in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • repression of WNT target genes
  • NOTCH1 Intracellular Domain Regulates Transcription
  • deletions in the AMER1 gene destabilize the destruction complex
  • AMER1 mutants destabilize the destruction complex
  • TCF dependent signaling in response to WNT
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by WNT in cancer
HHEX and KRTAP10-5 hematopoietically expressed homeobox keratin associated protein 10-5
HHEX and KRTAP10-7 hematopoietically expressed homeobox keratin associated protein 10-7
HHEX and PSMA3 hematopoietically expressed homeobox proteasome (prosome, macropain) subunit, alpha type, 3
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • T41 mutants of beta-catenin aren't phosphorylated
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • Stabilization of p53
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Mitotic G1-G1/S phases
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • DNA Replication Pre-Initiation
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Autodegradation of the E3 ubiquitin ligase COP1
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • PCP/CE pathway
  • Adaptive Immune System
  • CDK-mediated phosphorylation and removal of Cdc6
  • Hedgehog ligand biogenesis
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Separation of Sister Chromatids
  • HIV Infection
  • Ubiquitin-dependent degradation of Cyclin D
  • APC truncation mutants have impaired AXIN binding
  • Assembly of the pre-replicative complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • p53-Dependent G1 DNA Damage Response
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • p53-Independent DNA Damage Response
  • p53-Independent G1/S DNA damage checkpoint
  • G1/S DNA Damage Checkpoints
  • Vpu mediated degradation of CD4
  • Synthesis of DNA
  • M/G1 Transition
  • Ubiquitin-dependent degradation of Cyclin D1
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Signaling by Hedgehog
  • Regulation of mitotic cell cycle
  • Degradation of GLI1 by the proteasome
  • degradation of DVL
  • Cell Cycle Checkpoints
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • p53-Dependent G1/S DNA damage checkpoint
  • truncated APC mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • CDK-mediated phosphorylation and removal of Cdc6
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • truncations of AMER1 destabilize the destruction complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Host Interactions of HIV factors
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Cyclin A:Cdk2-associated events at S phase entry
  • SCF(Skp2)-mediated degradation of p27/p21
  • Mitotic Metaphase and Anaphase
  • Regulation of ornithine decarboxylase (ODC)
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • M Phase
  • APC truncation mutants are not K63 polyubiquitinated
  • Metabolism of amino acids and derivatives
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • Regulation of DNA replication
  • Cell Cycle, Mitotic
  • beta-catenin independent WNT signaling
  • Orc1 removal from chromatin
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Cross-presentation of soluble exogenous antigens (endosomes)
  • Antigen processing-Cross presentation
  • CDT1 association with the CDC6:ORC:origin complex
  • ER-Phagosome pathway
HHEX and TRMT6 hematopoietically expressed homeobox tRNA methyltransferase 6
HHEX and KRTAP10-8 hematopoietically expressed homeobox keratin associated protein 10-8
HHEX and EFEMP2 hematopoietically expressed homeobox EGF containing fibulin-like extracellular matrix protein 2
  • Molecules associated with elastic fibres
  • Elastic fibre formation
HHEX and KRTAP10-3 hematopoietically expressed homeobox keratin associated protein 10-3
HHEX and PML hematopoietically expressed homeobox promyelocytic leukemia
  • Interferon gamma signaling
  • Interferon Signaling
  • Cytokine Signaling in Immune system
HHEX and SOX8 hematopoietically expressed homeobox SRY (sex determining region Y)-box 8
HLA-DMA and HLA-DRB1 major histocompatibility complex, class II, DM alpha major histocompatibility complex, class II, DR beta 1
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DQA2 and HLA-DQB1 major histocompatibility complex, class II, DQ alpha 2 major histocompatibility complex, class II, DQ beta 1
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRA and HLA-DRB1 major histocompatibility complex, class II, DR alpha major histocompatibility complex, class II, DR beta 1
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and MAGEA3 major histocompatibility complex, class II, DR beta 1 melanoma antigen family A, 3
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and TRA major histocompatibility complex, class II, DR beta 1 T cell receptor alpha locus
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and TRB major histocompatibility complex, class II, DR beta 1 T cell receptor beta locus
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and TRIM21 major histocompatibility complex, class II, DR beta 1 tripartite motif containing 21
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Interferon gamma signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Regulation of innate immune responses to cytosolic DNA
  • Cytosolic sensors of pathogen-associated DNA
  • STING mediated induction of host immune responses
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Class I MHC mediated antigen processing & presentation
  • Innate Immune System
  • Adaptive Immune System
HLA-DRB1 and ZDHHC17 major histocompatibility complex, class II, DR beta 1 zinc finger, DHHC-type containing 17
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HMGA1 and PPARG high mobility group AT-hook 1 peroxisome proliferator-activated receptor gamma
  • DNA Damage/Telomere Stress Induced Senescence
  • Vpr-mediated nuclear import of PICs
  • HIV Infection
  • Cellular Senescence
  • Host Interactions of HIV factors
  • Integration of provirus
  • Interactions of Vpr with host cellular proteins
  • Early Phase of HIV Life Cycle
  • Autointegration results in viral DNA circles
  • HIV Life Cycle
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • 2-LTR circle formation
  • Integration of viral DNA into host genomic DNA
  • APOBEC3G mediated resistance to HIV-1 infection
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Icosapent
  • Troglitazone
  • Mesalazine
  • Indomethacin
  • Rosiglitazone
  • Nateglinide
  • Sulfasalazine
  • Repaglinide
  • Telmisartan
  • Balsalazide
  • Ibuprofen
  • Glipizide
  • Pioglitazone
  • Mitiglinide
  • Bezafibrate
  • (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid
  • 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
  • (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
  • (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
  • 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
  • (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid
  • (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid
  • (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid
  • (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid
  • (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid
  • difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron
  • (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID
  • 3-(5-methoxy-1H-indol-3-yl)propanoic acid
  • 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid
  • (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
  • 2-chloro-5-nitro-N-phenylbenzamide
  • (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
  • 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
  • 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
  • (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid
  • ALEGLITAZAR
NR4A1 and PPARG nuclear receptor subfamily 4, group A, member 1 peroxisome proliferator-activated receptor gamma
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • PIP3 activates AKT signaling
  • Nuclear Receptor transcription pathway
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • PI3K/AKT activation
  • Generic Transcription Pathway
  • PI-3K cascade
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signaling by PDGF
  • DAP12 interactions
  • Signalling by NGF
  • GAB1 signalosome
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • AKT phosphorylates targets in the nucleus
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Generic Transcription Pathway
  • Transcriptional regulation of white adipocyte differentiation
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Icosapent
  • Troglitazone
  • Mesalazine
  • Indomethacin
  • Rosiglitazone
  • Nateglinide
  • Sulfasalazine
  • Repaglinide
  • Telmisartan
  • Balsalazide
  • Ibuprofen
  • Glipizide
  • Pioglitazone
  • Mitiglinide
  • Bezafibrate
  • (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid
  • 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
  • (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
  • (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
  • 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
  • (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid
  • (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid
  • (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid
  • (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid
  • (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid
  • difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron
  • (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID
  • 3-(5-methoxy-1H-indol-3-yl)propanoic acid
  • 3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid
  • (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
  • 2-chloro-5-nitro-N-phenylbenzamide
  • (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
  • 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
  • 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
  • (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid
  • ALEGLITAZAR

Page 17 out of 155 pages